Jorge Arcuri

Oncologo Clinico, orgulloso papa de 4

[Jorge Arcuri @Gulitracio]

LA NACION - La historia de Bernard Nathanson, el médico de los 75.000 abortos que se hizo líder pro vida - https://t.co/yKxlAjDG4G

[Paolo Tarantino @PTarantinoMD]

Large (18k patients) metanalysis evaluating the benefit of adding adjuvant anthracyclines to taxanes for EBC

No benefit with anthracyclines when administered sequentially after taxanes (vs higher dose taxanes)

Unexpected benefit with concomitant administration

[Rana McKay, MD, FASCO @DrRanaMcKay]

Landmark day in kidney cancer history. Adjuvant pembrolizumab now FDA approved in RCC at high risk of relapse post nephrectomy. Game changer. Congrats ⁦@DrChoueiri⁩ ⁦@tompowles1⁩ https://t.co/od86pAAzkM

[microBIO @microBIOblog]

Este video es magnífico: cómo funciona la vacuna de RNA, cómo estimula tu sistema inmune.
https://t.co/OJ8ZjD66Lo

[Jorge Arcuri @Gulitracio]

@FAndreMD @AACR Congrats Fabrice!!

[Jorge Arcuri @Gulitracio]

@damienrobi @StevieWonder @LionelRichie @LoveTinaTurner @bobdylan @springsteen @realdarylhall @kennyloggins @cyndilauper @michaeljackson @DianaRoss @WillieNelson @PaulSimonMusic @QuincyDJones @billyjoel @JourneyOfficial @dionnewarwick @HueyLewisNews 👏🏻👏🏻👏🏻👏🏻👏🏻🙌🏻🙌🏻🙌🏻

[FabriceAndre @FAndreMD]

Preliminary OS results of MonarchE in overall pop and in the pop where the drug is approved by FDA . MonarchE assessed efficacy of Abemaciclib , a CDK4/6 inh in pts with HR+/her2- eBChttps://www.annalsofoncology.org/article/S0923-7534(21)04551-8/fulltext#.YXxIy37LgUA.twitter

[Jorge Arcuri @Gulitracio]

Modulo en vivo de tumores genitourinarios, viernes 29, https://t.co/p6PxtaH9KC No te lo podes perder! @aaoncoclinica @jpsade2 @Martin_AngelMD @cdanicas @drenriquegrande @FedericoCayol @fedelosco

[Martín Angel @Martin_AngelMD]

1⃣ day to go‼️ UroTarget 2021. #GUcsm
🗓️ 22 & 23 October. 🇪🇸🇦🇷🇺🇾🇺🇸
📍 Mendoza City. Hibrid mode
⭕️ Live discussion #MultidisciplinaryWork
⭕️ Symposiums @fedelosco
⭕️ Academic Lectures @drenriquegrande @DrRanaMcKay
⭕️ Masterclass @DrChoueiri @cdanicas

[FDA Oncology @FDAOncology]

FDA approved atezolizumab (Tecentriq, Genentech) for adjuvant treatment following resection and platinum-based chemotherapy stage II-IIIA NSCLC with PD-L1 expression on ≥1% of tumor cells. FDA also approved VENTANA PD-L1 (SP263) Assay as a CDx.
#lcsm
https://t.co/iwxIvZaCcY

[Lorenzo Gerratana @LGerratana]

The updated follow-up of the monarchE study confirms the emerging role of Abemaciclib in the adjuvant setting of high risk Early #BreastCancer. Now it's time to design new effective #biomarkers to further #personalize the treatment algorithm @myESMO #ESMOVirtualPlenary #EBC #bcsm

[Mauricio Fernandez Lazzaro @mflazzaro_gu]

Our references, Our friends. All in 1 in UroTarget. 22-23 Oct. OnLine Mode & reduced face-to-face. Stay Tuned!
@DrChoueiri @drenriquegrande @cdanicas @jpsade2
#urooncology #gu #oncology #urology #mendoza #sciencetwitter

[Aditya Bardia, MD @dradityabardia]

Today FDA approved abemaciclib with endocrine therapy for adjuvant treatment of high-risk HR+/HER2- breast cancer & Ki-67 score ≥20%, based on MONARCH-E. Also approved Ki-67 IHC MIB-1 (Dako Omnis) assay. 1st adjuvant CDK 4/6 inh approved. #bcsm @OncoAlert @asco FDA alert.

[luis Fein @LuisFein]

A pesar de los beneficios del screening en cancer persisten importantes disparidades por la menor aceptación de los exámenes de detección de entre las minorías raciales, étnicas, sexuales y de género y las poblaciones médicamente desatendidas https://t.co/aK2aPmnBlM

[Jorge Arcuri @Gulitracio]

Muchas gracias ⁦@aaoncoclinica⁩

[Jorge Arcuri @Gulitracio]

Post Europeo 2021, todo lo presentado en cancer ginecologico.⁦@aaoncoclinica⁩

[Jorge Arcuri @Gulitracio]

Muchas gracias a los organizadores y ⁦@aaoncoclinica⁩

[FabriceAndre @FAndreMD]

The 5 year OS wall has been broken by Ribo for pts with endocrine sensitive stage IV BC . A milestone in oncology. When I saw the data first time, it came to my mind the very low 5 y OS I was learning when I was student #ESMO21

[Jorge Arcuri @Gulitracio]

Congrats ⁦@ggabuin⁩! Great discussion at #ESMO21 Metastatic Breast Cancer Session! Two impressive trials: KN 355 and Monaleesa-2